KALYDECO
As listed in the register: KALYDECO
150 mg · tablet
- Prescription only
- Breathing, airways, allergies and cough
- Active substance
- Ivacaftor
- Made by
- Vertex Pharmaceuticals (Canada) Incorporated
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Kalydeco). It describes the substance, not this exact product.
Ivacaftor is a potentiator of the CFTR protein.
The CFTR protein is a chloride channel present at the surface of epithelial cells in multiple organs.
Ivacaftor is extensively metabolized in humans.
Following oral administration, the majority of ivacaftor (87.8%) is eliminated in the feces after metabolic conversion.
The exposure of ivacaftor increased approximately 2.5- to 4-fold when given with food that contains fat.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-03-23
Safety of the active substance
From the US prescribing label for the same active substance (Kalydeco). It describes the substance, not this exact product.
The most common adverse reactions in the 221 patients treated with KALYDECO were headache (17%), upper respiratory tract infection (16%), nasal congestion (16%), nausea (10%), rash (10%), rhinitis (6%), dizziness (5%), arthralgia (5%), and bacteria in sputum (5%).
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
Spain9 matching products
- KALYDECO 150 mg · comprimido recubierto con película2 makers
- IVACAFTOR ACCORD 150 mg · comprimido recubierto con película
- IVACAFTOR AUROVITAS 150 mg · comprimido recubierto con película
- IVACAFTOR INTAS 150 mg · comprimido recubierto con película
- IVACAFTOR STADA 150 mg · comprimido recubierto con película
- IVACAFTOR SUN 150 mg · comprimido recubierto con película
- IVACAFTOR TEVA 150 mg · comprimido recubierto con película
- PEFALPOV 150 mg · comprimido recubierto con película
Netherlands7 matching products
- Ivacaftor Aurobindo 150 mg 150 mg · filmomhulde tablet
- Ivacaftor Intas 150 mg filmomhulde tabletten 150 mg · filmomhulde tablet
- Ivacaftor STADA 150 mg 150 mg · filmomhulde tablet
- Ivacaftor SUN 150 mg filmomhulde tabletten 150 mg · filmomhulde tablet
- Ivacaftor Teva 150 mg 150 mg · filmomhulde tablet
- Ivafib 150 mg filmomhulde tabletten 150 mg · filmomhulde tablet
- Kalydeco 150 mg filmomhulde tabletten 150 mg · filmomhulde tablet
SwitzerlandNo exact match for this strength and form
Details
| Made by | Vertex Pharmaceuticals (Canada) Incorporated |
|---|---|
| Active substance | Ivacaftor |
| Used in | Breathing, airways, allergies and cough |
| Strength | 150 mg |
| Form | tablet |
| Classification | R07AX02 · Breathing, airways, allergies and cough |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02397412 |
| DPD drug code | 88237 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
5 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.